#USA #Clinical Trials #Research Triangle Park #Health Technology #TruTechnologies

TruLab Rebrands to TruTechnologies: A New Era in Clinical Trials

TruLab, a prominent player in the field of clinical trial sample management, has recently announced a significant rebranding to TruTechnologies. This transition reflects a broader mission to address and innovate upon complex challenges faced in clinical trials. The company aims to enhance clinical trial oversight and provide patient-centered solutions that address long-standing issues prevalent in the industry.

Since its inception in 2018, TruLab has established itself as a leader in sample tracking excellence. However, over the past six years, it has become evident that the company's innovations extend beyond just tracking samples. One of the most pressing challenges in clinical trials is the issue of lost and mishandled samples. It is reported that up to 20% of trial samples can become unusable due to these inefficiencies, causing undue burdens on patients. Often, this situation necessitates repeat visits, and, in severe cases, may even lead to patient exclusion from trials. These challenges deeply affect patient recruitment and retention, issues that TruTechnologies aims to counteract effectively.

Scott Ogle, the CEO of TruTechnologies, commented on the rebranding, stating that solving the sample tracking issue opened up pathways to address various aspects of protocol compliance. He emphasizes, "By giving sponsors new visibility into study execution, we're not only shining a light on previously unseeable parts of a trial but also building systems that reduce inefficiencies and ultimately create safer, more streamlined patient experiences." This insight into clinical trial execution marks a significant step forward in optimizing study management and enhancing patient safety.

As part of this rebranding, the term "TruLab" will now specifically refer to the company's flagship sample management product, while TruTechnologies will pave the way for new solutions that tackle additional areas of clinical trial oversight. Among the innovations is a groundbreaking product called TruDose, specifically designed to mitigate errors in the management and administration of investigational products during trials. This addresses a critical area where oversight can lead to severe patient safety violations, highlighting the necessity of fulfilling mandatory protocol requirements.

The importance of medical oversight can't be overstated. A recent alarming scenario unfolded in one clinical trial where a dose was dispensed without the required pre-dose blood alcohol test, a critical protocol step. Such lapses not only breach compliance but pose serious risks to patient safety. TruDose aims to prevent these types of errors by ensuring all requirements are met before administering doses, thereby reinforcing a safer trial environment.

Early stages of clinical trials — notably screening and enrollment — pose significant challenges that TruTechnologies is poised to tackle with its proven technologies. The company will unveil a new, streamlined product aimed at addressing these initial phases at the esteemed SCOPE Summit in Orlando, which stands as a key event in the clinical operations industry. Attendees can expect groundbreaking announcements that will further elucidate our commitment to innovative, patient-first solutions.

Founded in 2018, TruTechnologies has quickly ascended to become a top provider of real-time clinical trial oversight solutions. The company has partnered with leading pharmaceutical corporations and biotech firms, emphasizing timely and high-quality data while meticulously managing risks associated with drug development processes. TruTechnologies is dedicated to optimizing patient screening and enrollment while reinforcing compliance with protocols and correcting deviations before they escalate.

To learn more about TruTechnologies and its revolutionary solutions, visit TruTechnologies.io and connect on LinkedIn for the latest updates in clinical trial management.